JP2015533369A5 - - Google Patents

Download PDF

Info

Publication number
JP2015533369A5
JP2015533369A5 JP2015537233A JP2015537233A JP2015533369A5 JP 2015533369 A5 JP2015533369 A5 JP 2015533369A5 JP 2015537233 A JP2015537233 A JP 2015537233A JP 2015537233 A JP2015537233 A JP 2015537233A JP 2015533369 A5 JP2015533369 A5 JP 2015533369A5
Authority
JP
Japan
Prior art keywords
sodium
potassium
pharmaceutical composition
composition according
octadecanoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015537233A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015533369A (ja
JP6285447B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/071575 external-priority patent/WO2014060447A1/en
Publication of JP2015533369A publication Critical patent/JP2015533369A/ja
Publication of JP2015533369A5 publication Critical patent/JP2015533369A5/ja
Application granted granted Critical
Publication of JP6285447B2 publication Critical patent/JP6285447B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015537233A 2012-10-17 2013-10-16 経口ペプチド送達用の脂肪酸アシル化ｄ−アミノ酸 Expired - Fee Related JP6285447B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP12188807.7 2012-10-17
EP12188807 2012-10-17
US201261715412P 2012-10-18 2012-10-18
US61/715,412 2012-10-18
PCT/EP2013/071575 WO2014060447A1 (en) 2012-10-17 2013-10-16 Fatty acid acylated d-amino acids for oral peptide delivery

Publications (3)

Publication Number Publication Date
JP2015533369A JP2015533369A (ja) 2015-11-24
JP2015533369A5 true JP2015533369A5 (enExample) 2016-12-01
JP6285447B2 JP6285447B2 (ja) 2018-02-28

Family

ID=47049061

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015537233A Expired - Fee Related JP6285447B2 (ja) 2012-10-17 2013-10-16 経口ペプチド送達用の脂肪酸アシル化ｄ−アミノ酸

Country Status (5)

Country Link
US (2) US20150265710A1 (enExample)
EP (1) EP2908846A1 (enExample)
JP (1) JP6285447B2 (enExample)
CN (1) CN104884078B (enExample)
WO (1) WO2014060447A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015162195A1 (en) * 2014-04-23 2015-10-29 Novo Nordisk A/S Fatty acid acylated amino acids for oral peptide delivery
CN115942970A (zh) * 2020-08-18 2023-04-07 密歇根大学董事会 N-酰基氨基酸产物及用途
EP4299057A1 (en) 2022-06-30 2024-01-03 Adocia Solid compositions comprising a peptide or a protein and an acylated amino acid
US20250000948A1 (en) 2021-11-15 2025-01-02 Adocia Solid compositions comprising a peptide or a protein and an acylated amino acid
EP4180060A1 (en) 2021-11-15 2023-05-17 Adocia Solid compositions comprising a peptide or a protein and an acylated amino acid
EP4299071A1 (en) * 2022-07-01 2024-01-03 Adocia Compositions comprising a peptide or a protein and an acylated amino acid

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966848A (en) * 1988-02-08 1990-10-30 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
JPH03236315A (ja) * 1989-12-05 1991-10-22 Nippon Oil & Fats Co Ltd 抗精神病薬
JPH0543889A (ja) * 1991-08-19 1993-02-23 Kanebo Ltd 洗浄剤組成物
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
FR2767064B1 (fr) * 1997-08-07 1999-11-12 Centre Nat Rech Scient Procede de liberation d'un principe actif contenu dans une emulsion multiple
EP1265638A1 (en) 1999-11-12 2002-12-18 Pharmaderm Laboratories Ltd. Compositions for transdermal and transmucosal administration of therapeutic agents
US6656499B1 (en) * 1999-11-12 2003-12-02 Pharmaderm Laboratories, Ltd. Composition for transdermal and dermal administration of interferon-α
FR2828102B1 (fr) * 2001-03-28 2004-07-09 Ifc Sa Utilisation des lipoaminoacides dans une composition pharmaceutique comme promoteur et systeme disperse a usage pharmaceutique contenant de tels composes
US6951655B2 (en) 2001-10-11 2005-10-04 Imi Biomed, Inc. Pro-micelle pharmaceutical compositions
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
BRPI0413276B8 (pt) 2003-08-05 2021-05-25 Novo Nordisk As derivado de insulina, complexo de zinco do mesmo, e, composição farmacêutica
US20050282756A1 (en) 2004-06-18 2005-12-22 Mehta Nozer M Oral delivery of peptide pharmaceutical compositions
US7544714B2 (en) * 2004-07-16 2009-06-09 University Of Massachusetts Lipid-amino acid conjugates and methods of use
EP1656951A1 (en) * 2004-11-12 2006-05-17 Xigen S.A. Conjugates with enhanced cell uptake activity
ES2601839T3 (es) 2006-09-22 2017-02-16 Novo Nordisk A/S Análogos de insulina resistentes a proteasas
EP2514406A1 (en) 2007-06-01 2012-10-24 Novo Nordisk A/S Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
DK2254906T3 (en) 2008-03-18 2017-01-23 Novo Nordisk As Protease-stabilized acylated insulin analogues
EP2370059A1 (en) * 2008-11-28 2011-10-05 Novo Nordisk A/S Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
JP5123922B2 (ja) 2009-12-02 2013-01-23 独立行政法人科学技術振興機構 融合糖タンパク質から成るエンベロープを有する逆行性輸送ウィルスベクター系
EP2696847A1 (en) * 2011-04-14 2014-02-19 Novo Nordisk A/S Fatty acid acylated amino acids for oral peptide delivery

Similar Documents

Publication Publication Date Title
JP2015533369A5 (enExample)
RU2491052C2 (ru) Противоперхотные композиции, содержащие пептиды
JP2018505146A5 (enExample)
EA201391756A1 (ru) Композиции, содержащие, способы, включающие, и применение производных доластатина, связанных с неприродными аминокислотами
RU2016133469A (ru) Композиции селеноорганических соединений и способы их применения
WO2015061720A3 (en) Prostacyclin compounds, compositions and methods of use thereof
WO2010000372A3 (en) New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
JP2016527277A5 (enExample)
JP2014514365A5 (enExample)
JP2010514768A5 (enExample)
BRPI0906104A2 (pt) "derivado de ácido nuclêico peptídico, composição farmacêutica contendo uma quantidade "terapeuticamente eficaz do derivado de ácido nuclêico peptídico, composição farmacêutica contendo uma quantidade terapeuticamente eficaz do derivado de ácido nuclêico peptídico,método de utilização do derivado de ácido nuclêico peptídico e composto"
CN101687022A8 (zh) Prame衍生的肽以及包括该肽的免疫原组合物
MY165152A (en) Cyclosporine analogue molecules modified at amino acid 1 and 3
WO2009046220A3 (en) Lipopeptides for delivery of nucleic acids
RU2015146614A (ru) Конъюгированная вакцина на основе пептида антигена wt1
EP3403650A3 (en) Pkc-activating compounds for the treatment of neurodegenerative diseases
EP2615112A3 (en) Purified immunoglobulin fusion proteins and methods of their purification
EP3279313A3 (en) Hyperblebbing shigella strains
MX2015014746A (es) Derivados de dolastatina 10 y auristatinas.
RU2014106757A (ru) Огнегасительная пена с содержанием силоксана
EP1614675A3 (en) Amino acids with affinity for the alpha-2-delta protein
NZ599791A (en) Therapeutic peptides
MX2009005299A (es) Maiz extraido con solvente.
NZ593524A (en) A nonapeptide with anti-tumour activity
RU2017126566A (ru) ВСТРЕЧАЮЩИЕСЯ В ПРИРОДЕ миРНК ДЛЯ КОНТРОЛИРОВАНИЯ ЭКСПРЕССИИ ГЕНОВ И ИХ ПРИМЕНЕНИЕ